In a previous study, CD44 was used to identify GC-initiating cells from a panel of human GC cell lines, and CD44-positive GC cells exhibited stem cell properties of self-renewal, as well as the ability to form differentiated progeny to give rise to CD44-negative cells [12]. The gene discussed is CD44; the disease is gastric cancer.